Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
2
조회
0
다운로드
12
인용
0
참고문헌
키워드
초록
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, advanced age, male sex, and low- and middle-income countries. The case fatality rate of ICH is high (40% at 1 month and 54% at 1 year), and only 12% to 39% of survivors can achieve long-term functional independence. Risk factors of ICH are hypertension, current smoking, excessive alcohol consumption, hypocholesterolemia, and drugs. Old age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) increase the risk of ICH. Clinical presentation varies according to the size and location of hematoma, and intraventricular extension of hemorrhage. Patients with CAA-related ICH frequently have concomitant cognitive impairment. Anticoagulation related ICH is increasing recently as the elderly population who have atrial fibrillation is increasing. As non-vitamin K antagonist oral anticoagulants (NOACs) are currently replacing warfarin, management of NOAC-associated ICH has become an emerging issue.
Abstract
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, advanced age, male sex, and low- and middle-income countries. The case fatality rate of ICH is high (40% at 1 month and 54% at 1 year), and only 12% to 39% of survivors can achieve long-term functional independence. Risk factors of ICH are hypertension, current smoking, excessive alcohol consumption, hypocholesterolemia, and drugs. Old age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) increase the risk of ICH. Clinical presentation varies according to the size and location of hematoma, and intraventricular extension of hemorrhage. Patients with CAA-related ICH frequently have concomitant cognitive impairment. Anticoagulation related ICH is increasing recently as the elderly population who have atrial fibrillation is increasing. As non-vitamin K antagonist oral anticoagulants (NOACs) are currently replacing warfarin, management of NOAC-associated ICH has become an emerging issue.
참고문헌 (85)
- Qureshi AI, "Intracerebral haemorrhage", Lancet, 373, pp.1632~1644 (2009)
- Qureshi AI, "Spontaneous intracerebral hemorrhage", N Engl J Med, 344, pp.1450~1460 (2001)
- Garcia JH, "Pathology of hypertensive arteriopathy", Neurosurg Clin N Am, 3, pp.497~507 (1992)
- Keun-Sik Hong, "Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke", 대한뇌졸중학회지, 15(1), pp.2~20 (2013), 대한뇌졸중학회[DOI]
- Krishnamurthi RV, "The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study", Glob Heart, 9, pp.101~106 (2014)
- Hemphill JC 3rd, "The ICH score: a simple, reliable grading scale for intracerebral hemorrhage", Stroke, 32, pp.891~897 (2001)
- Keep RF, "Intracerebral haemorrhage: mechanisms of injury and therapeutic targets", Lancet Neurol, 11, pp.720~731 (2012)
- Feigin VL, "Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review", Lancet Neurol, 8, pp.355~369 (2009)
- Sacco S, "Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry", Stroke, 40, pp.394~399 (2009)
- Kannel WB, "Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study", JAMA, 214, pp.301~310 (1970)
- Broderick J, "Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association", American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group, 2007, pp.38, 2001~2023
- Kazunori Toyoda, "Epidemiology and Registry Studies of Stroke in Japan", 대한뇌졸중학회지, 15(1), pp.21~26 (2013), 대한뇌졸중학회[DOI]
- van Asch CJ, "Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis", Lancet Neurol, 9, pp.167~176 (2010)
- Flaherty ML, "Racial variations in location and risk of intracerebral hemorrhage", Stroke, 36, pp.934~937 (2005)
- Broderick J, "Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage", J Neurosurg, 78, pp.188~191 (1993)
- Jolink WM, "Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage", Neurology, 85, pp.1318~1324 (2015)
- Stein M, "Intracerebral hemorrhage in the very old: future demographic trends of an aging population", Stroke, 43, pp.1126~1128 (2012)
- Lovelock CE, "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study", Lancet Neurol, 6, pp.487~493 (2007)
- González-Pérez A, "Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network)", Neurology, 81, pp.559~565 (2013)
- Liotta EM, "Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States", J Stroke Cerebrovasc Dis, 22, pp.1151~1155 (2013)
- Chan S, "Critical care management of intracerebral hemorrhage", Crit Care Clin, 30, pp.699~717 (2014)
- Fisher CM, "Lacunar strokes and infarcts: a review", Neurology, 32, pp.871~876 (1982)
- Charidimou A, "Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum", J Neurol Neurosurg Psychiatry, 83, pp.124~137 (2012)
- Rosand J, "Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study", Neurology, 55, pp.947~951 (2000)
- Rost NS, "The genetic architecture of intracerebral hemorrhage", Stroke, 39, pp.2166~2173 (2008)
- Phillips MC, "Apolipoprotein E isoforms and lipoprotein metabolism", IUBMB Life, 66, pp.616~623 (2014)
- Qureshi AI, "Apoptosis as a form of cell death in intracerebral hemorrhage", Neurosurgery, 52, pp.1041~1047 (2003)
- Qureshi AI, "Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study", Crit Care Med, 31, pp.1482~1489 (2003)
- Lusardi TA, "Effect of acute calcium influx after mechanical stretch injury in vitro on the viability of hippocampal neurons", J Neurotrauma, 21, pp.61~72 (2004)
- Graham DI, "Recent advances in neurotrauma", J Neuropathol Exp Neurol, 59, pp.641~651 (2000)
- Nakamura T, "Holo-transferrin and thrombin can interact to cause brain damage", Stroke, 36, pp.348~352 (2005)
- Xi G, "Mechanisms of brain injury after intracerebral haemorrhage", Lancet Neurol, 5, pp.53~63 (2006)
- Wagner KR, "Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma", Dev Neurosci, 24, pp.154~160 (2002)
- Xi G, "The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?", J Neurochem, 84, pp.3~9 (2003)
- Ariesen MJ, "Risk factors for intracerebral hemorrhage in the general population: a systematic review", Stroke, 34, pp.2060~2065 (2003)
- Sturgeon JD, "Risk factors for intracerebral hemorrhage in a pooled prospective study", Stroke, 38, pp.2718~2725 (2007)
- O’Donnell MJ, "Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study", Lancet, 376, pp.112~123 (2010)
- Zia E, "Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant", Stroke, 38, pp.2681~2685 (2007)
- Martini SR, "Risk factors for intracerebral hemorrhage differ according to hemorrhage location", Neurology, 79, pp.2275~2282 (2012)
- Jackson CA, "Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?", J Neurol Neurosurg Psychiatry, 77, pp.1244~1252 (2006)
- Grønbaek H, "Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study", BMC Gastroenterol, 8, pp.16~ (2008)
- Thrift AG, "Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group", Stroke, 27, pp.2020~2025 (1996)
- Mustanoja S, "Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage", Stroke, 44, pp.2330~2332 (2013)
- Flaherty ML, "Warfarin use leads to larger intracerebral hematomas", Neurology, 71, pp.1084~1089 (2008)
- Flaherty ML, "The increasing incidence of anticoagulant-associated intracerebral hemorrhage", Neurology, 68, pp.116~121 (2007)
- García-Rodríguez LA, "Antithrombotic drugs and risk of hemorrhagic stroke in the general population", Neurology, 81, pp.566~574 (2013)
- He J, "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials", JAMA, 280, pp.1930~1935 (1998)
- Hart RG, "Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses", Arch Neurol, 57, pp.326~332 (2000)
- Thompson BB, "Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review", Neurology, 75, pp.1333~1342 (2010)
- Naidech AM, "Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage", Stroke, 40, pp.2398~2401 (2009)
- Davis SM, "Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage", Neurology, 66, pp.1175~1181 (2006)
- ACTIVE Investigators, "Effect of clopidogrel added to aspirin in patients with atrial fibrillation", N Engl J Med, 360, pp.2066~2078 (2009)
- Kernan WN, "Phenylpropanolamine and the risk of hemorrhagic stroke", N Engl J Med, 343, pp.1826~1832 (2000)
- Yoon BW, "Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke", Neurology, 68, pp.146~149 (2007)
- Bos MJ, "Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study", Stroke, 38, pp.3127~3132 (2007)
- Ovbiagele B, "Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage", Stroke, 44, pp.2409~2413 (2013)
- Goos JD, "Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population", Neurology, 74, pp.1954~1960 (2010)
- Jeerakathil T, "Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study", Stroke, 35, pp.1831~1835 (2004)
- Cordonnier C, "Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting", Brain, 130, pp.1988~2003 (2007)
- Charidimou A, "Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts", Stroke, 44, pp.995~1001 (2013)
- Lovelock CE, "Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies", Stroke, 41, pp.1222~1228 (2010)
- Lee SH, "Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage", Neurology, 72, pp.171~176 (2009)
- Jung SY, "Parity and risk of hemorrhagic strokes", Neurology, 74, pp.1424~1429 (2010)
- Kim BJ, "Excessive work and risk of haemorrhagic stroke: a nationwide case-control study", Int J Stroke, 8(Suppl A100), pp.56~61 (2013)
- Kim TJ, "Prolonged sleep increases the risk of intracerebral haemorrhage: a nationwide case-control study", Eur J Neurol, 23, pp.1036~1043 (2016)
- Poungvarin N, "Grave prognosis on spontaneous intracerebral haemorrhage: GP on STAGE score", J Med Assoc Thai, 89(Suppl 5), pp.S84~S93 (2006)
- Chen HS, "Risk factors of in-hospital mortality of intracerebral hemorrhage and comparison of ICH scores in a Taiwanese population", Eur Neurol, 66, pp.59~63 (2011)
- Lee SH, "White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study", Neurology, 74, pp.1502~1510 (2010)
- Lee SH, "Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study", Diabetologia, 53, pp.429~434 (2010)
- Miyagi T, "Reduced estimated glomerular filtration rate affects outcomes 3 months after intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study", J Stroke Cerebrovasc Dis, 24, pp.176~182 (2015)
- Zahuranec DB, "Early care limitations independently predict mortality after intracerebral hemorrhage", Neurology, 68, pp.1651~1657 (2007)
- Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2015, pp.46, 2032~2060
- Manno EM, "Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage", Mayo Clin Proc, 80, pp.420~433 (2005)
- Steiner T, "Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee", Cerebrovasc Dis, 22, pp.294~316 (2006)
- Vespa PM, "Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome", Neurology, 60, pp.1441~1446 (2003)
- Vinters HV, "Cerebral amyloid angiopathy. A critical review", Stroke, 18, pp.311~324 (1987)
- Yoshimura M, "Dementia in cerebral amyloid angiopathy: a clinicopathological study", J Neurol, 239, pp.441~450 (1992)
- Fang MC, "Death and disability from warfarin-associated intracranial and extracranial hemorrhages", Am J Med, 120, pp.700~705 (2007)
- Kase CS, "Anticoagulant-related intracerebral hemorrhage", Neurology, 35, pp.943~948 (1985)
- Fredriksson K, "Emergency reversal of anticoagulation after intracerebral hemorrhage", Stroke, 23, pp.972~977 (1992)
- Livoni JP, "Intracranial fluid-blood levels in the anticoagulated patient", Neuroradiology, 25, pp.335~337 (1983)
- Wilson D, "Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type", Neurology, 86, pp.360~366 (2016)
- Connolly SJ, "Andexanet alfa for acute major bleeding associated with factor Xa inhibitors", N Engl J Med, 375, pp.1131~1141 (2016)
- Siegal DM, "Andexanet alfa for the reversal of factor Xa inhibitor activity", N Engl J Med, 373, pp.2413~2424 (2015)
- Pollack CV Jr, "Idarucizumab for dabigatran reversal", N Engl J Med, 373, pp.511~520 (2015)
